Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence
Researchers have developed and validated a machine learning–based method to predict which patients with early-stage melanoma are most likely to experience a cancer recurrence.
Materials provided by Massachusetts General Hospital. Note: Content may be edited for style and length.
Source link aaaaa